Matches in Wikidata for { <http://www.wikidata.org/entity/Q64611821> ?p ?o ?g. }
Showing items 1 to 30 of
30
with 100 items per page.
- Q64611821 description "clinical trial" @default.
- Q64611821 description "ensayu clínicu" @default.
- Q64611821 description "klinisch onderzoek" @default.
- Q64611821 description "клінічне випробування" @default.
- Q64611821 name "Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)" @default.
- Q64611821 type Item @default.
- Q64611821 label "Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)" @default.
- Q64611821 prefLabel "Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)" @default.
- Q64611821 P1132 Q64611821-4A062F36-9FFD-4CA9-946E-DA0769010A36 @default.
- Q64611821 P1476 Q64611821-44FB359C-D2CF-4890-BF76-1FBD5124EE83 @default.
- Q64611821 P17 Q64611821-64323A80-881B-490C-AED6-F26BDB660C83 @default.
- Q64611821 P2899 Q64611821-FA580A83-3541-4406-AB1A-5C38BDC80D70 @default.
- Q64611821 P3098 Q64611821-690154BC-DF13-4465-8FAF-71E471824D59 @default.
- Q64611821 P31 Q64611821-1E26D1A1-4784-4ABC-9F13-C2279C00D0C3 @default.
- Q64611821 P4135 Q64611821-46305040-2949-4A55-8E5B-A8A0BD1F62D2 @default.
- Q64611821 P580 Q64611821-A7E67C92-DFC8-498F-A987-FA1D2B882AB7 @default.
- Q64611821 P582 Q64611821-F75B3A58-DED2-4B50-8A8F-01BA226530C1 @default.
- Q64611821 P6099 Q64611821-87F3537E-89F5-49B3-8589-F57303668565 @default.
- Q64611821 P8363 Q64611821-494AC606-83C8-4083-9423-893FC8D864FD @default.
- Q64611821 P1132 "+216" @default.
- Q64611821 P1476 "A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Alirocumab in Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia Not Adequately Controlled With Their Lipid Modifying Therapy" @default.
- Q64611821 P17 Q17 @default.
- Q64611821 P2899 "+20" @default.
- Q64611821 P3098 "NCT02107898" @default.
- Q64611821 P31 Q30612 @default.
- Q64611821 P4135 "+80" @default.
- Q64611821 P580 "2014-03-01T00:00:00Z" @default.
- Q64611821 P582 "2015-01-01T00:00:00Z" @default.
- Q64611821 P6099 Q42824827 @default.
- Q64611821 P8363 Q78089383 @default.